DiaMedica Therapeutics Inc Capital Reinvestment Ratio

Latest as of September 2010: 0.03x

DiaMedica Therapeutics Inc capital reinvestment ratio. DiaMedica Therapeutics Inc (DMAC) has a Capital Reinvestment Ratio of 0.03x as of September 2010, meaning it reinvests 0% of its operating cash flow ($392.76K) in capital expenditures ($11.57K). Check DMAC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$392.76K

USD

Capital Expenditures

$11.57K

USD

Data as of

Sep 2010

Most recent filing

DiaMedica Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

DiaMedica Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see DMAC cash generation efficiency.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow